Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Black Diamond Therapeutics, Inc. | Director | Common Stock | 10.1K | $25.4K | $2.50 | Dec 13, 2024 | Direct |
Black Diamond Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 30.6K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BDTX | Black Diamond Therapeutics, Inc. | Dec 13, 2024 | 1 | $12.9K | 4 | Dec 16, 2024 | Director |
BDTX | Black Diamond Therapeutics, Inc. | Sep 20, 2024 | 1 | $12.9K | 4 | Sep 20, 2024 | Director |
BDTX | Black Diamond Therapeutics, Inc. | Jun 21, 2024 | 1 | $11.5K | 4 | Jun 21, 2024 | Director |
BDTX | Black Diamond Therapeutics, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 6, 2024 | Director |
BDTX | Black Diamond Therapeutics, Inc. | Apr 10, 2024 | 1 | $0 | 4 | Apr 12, 2024 | Director |
BDTX | Black Diamond Therapeutics, Inc. | Apr 10, 2024 | 0 | $0 | 3 | Apr 12, 2024 | Director |